The impressive growth trajectory is primarily attributed to increasing demand for recombinant proteins, rising adoption of sustainable production technologies, and continuous advancements in molecular biology and genetic engineering techniques.
Read MoreRising awareness regarding hospital-acquired infections and growing investments in healthcare modernization are expected to boost antibiotic adoption across these regions.
Read MoreMarket players investing in cost-effective, rapid, and highly accurate testing kits are expected to gain a competitive advantage in these developing regions.
Read MoreOne of the most significant trends is the increasing demand for point-of-care testing solutions that provide rapid and accurate results in decentralized healthcare settings.
Read MoreOne of the most significant trends is the increasing demand for point-of-care testing solutions that provide rapid and accurate results in decentralized healthcare settings.
Read More